Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilufer Broeders

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Kidney International|January 12, 2002
Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal diseaseNilufer Broeders, Daniel Abramowicz
American Journal of Medical Genetics. Part A|June 25, 2004
A novel mutation of tumor necrosis factor receptor alpha type 1 associated with TRAPS and amyloidosisE Nilufer Broeders, Daniel Abramowicz, Marc J Abramowicz, et al.
Transplantation|February 17, 2005
A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroidsK Martin Wissing, Nilufer Broeders, Rodrigo Moreno-Reyes, et al.
Transplantation|September 29, 2006
Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantationKarl Martin Wissing, Philippe Unger, Lydia Ghisdal, et al.
Kidney International Reports|January 11, 2018
Donor Cancer Transmission in Kidney TransplantationThomas E R Baudoux, Karine Gastaldello, Sandrine Rorive, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 1, 2007
Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literatureLidia Ghisdal, Nora Ben Bouchta, Nilufer Broeders, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 13, 2016
Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft functionEmine Nilufer Broeders, Anwar Hamade, Fadoua El Mountahi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 24, 2008
Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effectsDaniel Abramowicz, Karine Hadaya, Marc Hazzan, et al.
Clinical Nephrology|October 11, 2017
Severe myoglobinuric acute kidney injury in a kidney recipient: rapid recovery after hemodialysis with the super high-flux membrane Theralite®
Ahmed Goubella, Fabrice Gankam-Kengne, Thomas Baudoux, et al.
Clinical Nephrology|December 6, 2012
Large decrease of anti-tetanus anatoxin and anti-pneumococcal antibodies at one year after renal transplantationEmine Nilufer Broeders, Karl M Wissing, Lidia Ghisdal, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Kidney International|January 12, 2002
Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal diseaseNilufer Broeders, Daniel Abramowicz
American Journal of Medical Genetics. Part A|June 25, 2004
A novel mutation of tumor necrosis factor receptor alpha type 1 associated with TRAPS and amyloidosisE Nilufer Broeders, Daniel Abramowicz, Marc J Abramowicz, et al.
Transplantation|February 17, 2005
A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroidsK Martin Wissing, Nilufer Broeders, Rodrigo Moreno-Reyes, et al.
Transplantation|September 29, 2006
Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantationKarl Martin Wissing, Philippe Unger, Lydia Ghisdal, et al.
Kidney International Reports|January 11, 2018
Donor Cancer Transmission in Kidney TransplantationThomas E R Baudoux, Karine Gastaldello, Sandrine Rorive, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 1, 2007
Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literatureLidia Ghisdal, Nora Ben Bouchta, Nilufer Broeders, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 13, 2016
Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft functionEmine Nilufer Broeders, Anwar Hamade, Fadoua El Mountahi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 24, 2008
Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effectsDaniel Abramowicz, Karine Hadaya, Marc Hazzan, et al.
Clinical Nephrology|October 11, 2017
Severe myoglobinuric acute kidney injury in a kidney recipient: rapid recovery after hemodialysis with the super high-flux membrane Theralite®
Ahmed Goubella, Fabrice Gankam-Kengne, Thomas Baudoux, et al.
Clinical Nephrology|December 6, 2012
Large decrease of anti-tetanus anatoxin and anti-pneumococcal antibodies at one year after renal transplantationEmine Nilufer Broeders, Karl M Wissing, Lidia Ghisdal, et al.
Pageof 3